Renaissance Technologies - UNITY BIOTECHNOLOGY INC ownership

UNITY BIOTECHNOLOGY INC's ticker is and the CUSIP is 91381U200. A total of 44 filers reported holding UNITY BIOTECHNOLOGY INC in Q4 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of UNITY BIOTECHNOLOGY INC
ValueSharesWeighting
Q2 2024$87,186
+49720.6%
64,582
-39.6%
0.00%
Q1 2024$175
+136.5%
106,941
+180.2%
0.00%
Q4 2023$74
-19.6%
38,171
-0.5%
0.00%
Q3 2023$92
-14.8%
38,371
-9.7%
0.00%
Q2 2023$108
-14.3%
42,471
-45.2%
0.00%
Q1 2023$126
-49.6%
77,471
-15.0%
0.00%
Q4 2022$25091,1710.00%
Other shareholders
UNITY BIOTECHNOLOGY INC shareholders Q4 2023
NameSharesValueWeighting ↓
Founders Fund V Management, LLC 491,751$134,7317.85%
ARCH Venture Management, LLC 1,004,817$2,753,1990.70%
683 Capital Management, LLC 240,000$657,6000.06%
Parkman Healthcare Partners LLC 42,749$117,1320.03%
CVI Holdings, LLC 74,100$203,0340.03%
Alyeska Investment Group, L.P. 697,448$1,911,0080.02%
Arete Wealth Advisors, LLC 10,392$140,582,9700.01%
Virtu Financial LLC 20,155$550.01%
Johnson Midwest Financial, LLC 661$20.01%
Cercano Management LLC 41,238$112,9920.01%
View complete list of UNITY BIOTECHNOLOGY INC shareholders